Waters Parkerson & CO. LLC Has $130,000 Stock Holdings in Walgreens Boots Alliance, Inc. (NASDAQ:WBA)

Waters Parkerson & CO. LLC reduced its position in shares of Walgreens Boots Alliance, Inc. (NASDAQ:WBA) by 11.5% during the second quarter, according to the company in its most recent 13F filing with the SEC. The firm owned 10,750 shares of the pharmacy operator’s stock after selling 1,400 shares during the quarter. Waters Parkerson & CO. LLC’s holdings in Walgreens Boots Alliance were worth $130,000 at the end of the most recent quarter.

Other institutional investors and hedge funds have also added to or reduced their stakes in the company. Norges Bank bought a new position in shares of Walgreens Boots Alliance in the fourth quarter valued at $29,816,000. Coldstream Capital Management Inc. acquired a new position in Walgreens Boots Alliance during the 4th quarter valued at about $326,000. D.A. Davidson & CO. increased its holdings in Walgreens Boots Alliance by 6.3% during the 4th quarter. D.A. Davidson & CO. now owns 57,780 shares of the pharmacy operator’s stock worth $1,509,000 after purchasing an additional 3,449 shares in the last quarter. Corient Private Wealth LLC raised its stake in shares of Walgreens Boots Alliance by 38.9% in the fourth quarter. Corient Private Wealth LLC now owns 280,545 shares of the pharmacy operator’s stock worth $7,325,000 after purchasing an additional 78,523 shares during the last quarter. Finally, Quest Partners LLC bought a new position in shares of Walgreens Boots Alliance in the fourth quarter valued at approximately $30,000. Institutional investors own 58.59% of the company’s stock.

Walgreens Boots Alliance Stock Down 3.0 %

WBA stock opened at $8.71 on Friday. The stock has a fifty day moving average of $10.29 and a 200-day moving average of $14.77. Walgreens Boots Alliance, Inc. has a fifty-two week low of $8.46 and a fifty-two week high of $27.05. The company has a market capitalization of $7.52 billion, a price-to-earnings ratio of -1.29, a PEG ratio of 1.02 and a beta of 0.70. The company has a debt-to-equity ratio of 0.49, a quick ratio of 0.31 and a current ratio of 0.65.

Walgreens Boots Alliance (NASDAQ:WBA) last issued its earnings results on Thursday, June 27th. The pharmacy operator reported $0.63 earnings per share for the quarter, missing analysts’ consensus estimates of $0.68 by ($0.05). Walgreens Boots Alliance had a positive return on equity of 12.63% and a negative net margin of 3.99%. The business had revenue of $36.40 billion for the quarter, compared to the consensus estimate of $35.94 billion. During the same quarter in the prior year, the business earned $1.00 EPS. Walgreens Boots Alliance’s revenue for the quarter was up 2.8% compared to the same quarter last year. As a group, equities research analysts predict that Walgreens Boots Alliance, Inc. will post 2.86 earnings per share for the current year.

Walgreens Boots Alliance Dividend Announcement

The firm also recently announced a quarterly dividend, which was paid on Thursday, September 12th. Shareholders of record on Wednesday, August 21st were issued a dividend of $0.25 per share. The ex-dividend date of this dividend was Wednesday, August 21st. This represents a $1.00 dividend on an annualized basis and a yield of 11.48%. Walgreens Boots Alliance’s payout ratio is -14.84%.

Analysts Set New Price Targets

Several brokerages recently issued reports on WBA. Morgan Stanley decreased their price target on Walgreens Boots Alliance from $13.00 to $9.00 and set an “underweight” rating for the company in a report on Friday, June 28th. Barclays lowered their target price on shares of Walgreens Boots Alliance from $11.00 to $7.00 and set an “underweight” rating for the company in a report on Tuesday, July 23rd. Evercore ISI dropped their price target on shares of Walgreens Boots Alliance from $17.00 to $10.00 and set an “in-line” rating on the stock in a research report on Friday, June 28th. JPMorgan Chase & Co. reduced their price objective on shares of Walgreens Boots Alliance from $20.00 to $15.00 and set an “overweight” rating for the company in a research report on Friday, August 30th. Finally, Bank of America dropped their target price on shares of Walgreens Boots Alliance from $11.00 to $7.50 and set an “underperform” rating on the stock in a research report on Wednesday, September 4th. Four investment analysts have rated the stock with a sell rating, ten have assigned a hold rating and two have issued a buy rating to the stock. According to MarketBeat, Walgreens Boots Alliance currently has a consensus rating of “Hold” and a consensus price target of $14.73.

About Walgreens Boots Alliance

Walgreens Boots Alliance, Inc operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise.